Article
The utility of a novel blood based biomarker in the diagnosis of pancreatic cancer
2021-01-01
Abstract excerpt
Pancreatic cancer maintains one of the worst prognoses of all malignancies. Fewer than 1% of patients survive 10-years post-diagnosis. It is an aggressive disease with as many as 80% of patients diagnosed in the most advanced stages of disease. This severely limits treatment options, contributing to the dismal prognosis. Diagnosis remains a challenge. Often, imaging alone cannot differentiate between benign or mal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2cefb59f-7c90-53bb-8c84-41e61f0f7769
- DOI
- 10.23889/suthesis.58274